Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Hinyokika Kiyo ; 54(1): 13-6, 2008 Jan.
Article in Japanese | MEDLINE | ID: mdl-18260354

ABSTRACT

We report a case of port-site metastasis of bladder cancer after left retroperitoneoscopy-assisted nephroureterectomy and cystectomy. The patient was a 73-year-old man with a chief complaint of gross hematuria. The diagnosis was invasive bladder cancer with bone metastasis. He received two courses of chemotherapy (methotrexate, vinblastine, adriamycin, cisplatin), and this resulted in resolution of the bone metastases. Two months later, abdominal and pelvic computed tomography showed a bladder tumor invading the left lower ureter with hydronephrosis. Left retroperitoneoscopy-assisted nephroureterectomy and cystectomy were performed. The patient was unable to undergo systemic chemotherapy because of renal dysfunction. Four months later, a lateral abdominal wall tumor was found at a port-site, and needle biopsy confirmed this to be metastatic urothelial carcinoma. Clinicians need to be aware of port-site metastasis, particularly in patients with UC, and take steps to prevent it during laparoscopic procedures.


Subject(s)
Abdominal Neoplasms/secondary , Carcinoma/surgery , Cystectomy , Endoscopy , Neoplasm Invasiveness , Neoplasm Seeding , Nephrectomy , Ureter/surgery , Ureteral Neoplasms/surgery , Urinary Bladder Neoplasms/surgery , Aged , Carcinoma/pathology , Endoscopy/adverse effects , Humans , Male , Ureteral Neoplasms/pathology , Urinary Bladder Neoplasms/pathology , Urothelium
2.
Hinyokika Kiyo ; 54(1): 29-34, 2008 Jan.
Article in Japanese | MEDLINE | ID: mdl-18260357

ABSTRACT

Prostatic stromal sarcoma (PSS) is an unusual lesion that is reported only occasionally. Here we describe a case of prostatic stromal sarcoma in a 33-year-old man who had complained of perineal pain. The serum prostate-specific antigen (PSA) level was above the normal limit at 5.8 ng/ml, and abdominal computed tomography (CT) revealed a giant mass in the retrovesical region. Chest CT demonstrated lung metastases. Specimens obtained by transrectal needle biopsy of the prostate suggested a mesenchymal tumor, but a precise diagnosis required a larger specimen. Palliative transurethral resection (TUR-P) was performed because of obstruction of the urogenital tract, and the final diagnosis was made from this specimen. The tumor contained yellowish gelatinous materials, and the stromal element appeared histologically malignant, with increased cellularity, mitotic figures and pleomorphism. The histological diagnosis was PSS, and the patient received VIP (etoposide, ifosfamide, cisplatin) chemotherapy regimen. However, the pelvic mass continued to increase in size, and the patient's condition rapidly deteriorated and he died. Sarcoma of the prostate gland showing aggressive behavior is quite rare. The detailed histological and immunohistochemical findings in this case are reported, together with a review of the literature.


Subject(s)
Prostatic Neoplasms/pathology , Sarcoma/pathology , Adult , Histocytochemistry , Humans , Lung Neoplasms/secondary , Male , Prostatic Neoplasms/diagnostic imaging , Sarcoma/diagnostic imaging , Tomography, X-Ray Computed , Transurethral Resection of Prostate
3.
Hinyokika Kiyo ; 53(10): 695-8, 2007 Oct.
Article in Japanese | MEDLINE | ID: mdl-18018584

ABSTRACT

Luteinizing hormone-releasing hormone agonist (LH-RH analogue) therapy, is one of the most widely used hormonal therapies. Recently, subcutaneous injection of a new long acting 3-month LHRH analogue depot has been developed. We investigated the adverse events induced by injection of an LH-RH analogue in 82 patients (median age was 75 year old, 59-87) using our questionnaire. Forty-eight and 34 cases had been administered leuprorelin acetate (LSR) and goserelin acetate (ZLA). The presentation rate of skin reaction was 8.8% (3/34) in the ZLA group and 14.6% (7/48) in the LSR group. There was no significant difference in rate of skin reaction between the LSR and ZLA group (p = 0.5113). Eight patients had induration (6 in LSR 2 in ZLA). We also present a case of subcutaneous granuloma formation at the injection site after using the three-month type preparation of leuprorelin acetate. We should be aware of the risk of skin reactions at the injection site and monitor carefully when using an LH-RH analogue.


Subject(s)
Antineoplastic Agents, Hormonal/administration & dosage , Antineoplastic Agents, Hormonal/adverse effects , Gonadotropin-Releasing Hormone/analogs & derivatives , Goserelin/administration & dosage , Goserelin/adverse effects , Granuloma/etiology , Leuprolide/administration & dosage , Leuprolide/adverse effects , Prostatic Neoplasms/drug therapy , Skin/pathology , Aged , Aged, 80 and over , Granuloma/pathology , Humans , Injections, Subcutaneous/adverse effects , Male , Middle Aged
4.
Hinyokika Kiyo ; 53(8): 565-9, 2007 Aug.
Article in Japanese | MEDLINE | ID: mdl-17874549

ABSTRACT

We report a case of a patient with a fistula between the left ureter and abdominal aorta. The patient was a 44-year-old male who had undergone radiation therapy (intraoperative: 25 Gy, external beam: 50 Gy) and chemotherapy (CDDP: 250 mg) for retroperitoneal lymph node metastasis from seminoma. His postoperative course was complicated by stenosis of bilateral ureters, which were treated by indwelling double J-stents. Fifteen years after the operation, gross hematuria occurred from the left ureteral orifice when exchanging the left ureteral double J-stent. Computed tomographic scan demonstrated left ureteral-abdominal aortic fistula formation at the crossing point. Massive hemorrhage was suspected to have prompt fistula formation between the left ureter and the aorta. At exploration, there was a fistula of about 7 mm in diameter at the anterior surface of the aorta, and the stent was presumably inserted from it. The aortic fistula was successfully closed. In addition, the left ureter was ligated proximal to the fistula and percutaneous left nephrostomy were performed. His postoperative course was uneventful. We should be aware that uretero-arterial fistula can occur as a serious complication of ureteral catheter exchange after prolonged ureteral stenting and radiation therapy.


Subject(s)
Aortic Diseases/etiology , Stents , Ureteral Diseases/etiology , Urinary Catheterization/adverse effects , Urinary Fistula/etiology , Vascular Fistula/etiology , Adult , Aorta, Abdominal , Humans , Lymph Nodes/pathology , Lymphatic Metastasis/radiotherapy , Male , Retroperitoneal Space , Seminoma/pathology , Seminoma/radiotherapy
5.
Hinyokika Kiyo ; 53(12): 869-73, 2007 Dec.
Article in Japanese | MEDLINE | ID: mdl-18203524

ABSTRACT

We report a case of adrenal metastasis from renal cell carcinoma. A 52-year-old man was referred to our hospital for a left renal mass. A computed tomography revealed a left renal tumor. Liver cirrhosis and splenomegaly were observed. Blood tests revealed pancytopenia; platelet count was 2.5 x 10(4)/mm3. The patient was treated by partial splenic embolization (PSE) in an attempt to ensure a safe nephrectomy. After the embolization, his platelet count increased to 6.1 x 10(4)/mm3, and left nephrectomy was performed successfully. Histopathological finding was renal cell carcinoma (RCC). We concluded that PSE before surgery was useful for the patients with thrombocytopenia due to hypersplenism. Four years after surgery, computed tomography revealed the presence of a mass on the right adrenal gland. He was suspected of having a non-functioning adrenal tumor. Metastasis of the RCC was suspected and right adrenalectomy was performed by a laparoscopic procedure. Histologically, the mass was identified as a RCC metastasis. It is clinically rare for an RCC metastasis to the contralateral adrenal gland to occur.


Subject(s)
Adrenal Gland Neoplasms/secondary , Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Liver Cirrhosis/complications , Adrenalectomy , Carcinoma, Renal Cell/diagnostic imaging , Carcinoma, Renal Cell/therapy , Humans , Kidney Neoplasms/diagnostic imaging , Kidney Neoplasms/therapy , Male , Middle Aged , Splenomegaly/complications , Tomography, X-Ray Computed
6.
Hinyokika Kiyo ; 52(9): 711-4, 2006 Sep.
Article in Japanese | MEDLINE | ID: mdl-17040057

ABSTRACT

Bladder carcinoma with skin metastasis is extremely rare. We herein report a case of a bladder tumor with skin metastasis. A 68-year-old man was referred to our hospital with macroscopic hematuria. Cystoscopy revealed a trigone papillary tumor. Transurethral resection of bladder tumor (TURBT) was performed and the pathological diagnosis was transitional cell carcinoma (TCC), pT1, G3. Thereafter, he received several courses of TURBT, intravesical chemotherapy (pirarubicin, bacillus Calmette-Guerin and mitomycin C) and intra-arterial chemotherapy because of recurrence. Thirteen years later, he underwent total cystoprostatectomy with neobladder formation. Histological examination revealed muscle-invasive bladder cancer with a staging of T3bNOM0. Two years and three months later, multiple firm nodules with eruptions appeared on the skin in several regions; they were resected and the histological findings revealed TCC. This indicated metastatic spread from the primary bladder TCC. He received only supportive treatment during this period due to renal dysfunction. He died four months after the manifestation of the skin metastasis due to multiple metastases.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Transitional Cell/secondary , Skin Neoplasms/secondary , Urinary Bladder Neoplasms/pathology , Administration, Intravesical , Aged , Carcinoma, Transitional Cell/drug therapy , Carcinoma, Transitional Cell/radiotherapy , Carcinoma, Transitional Cell/surgery , Cisplatin/administration & dosage , Combined Modality Therapy , Cystectomy , Doxorubicin/administration & dosage , Doxorubicin/analogs & derivatives , Humans , Infusions, Intra-Arterial , Male , Methotrexate/administration & dosage , Mitomycin/administration & dosage , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/radiotherapy , Urinary Bladder Neoplasms/surgery
7.
Intern Med ; 43(4): 336-9, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15168780

ABSTRACT

We report the rare case of HES involving oral cavity associated with esophagus, and gastrointestinal tract, which we succeeded in diagnosing precisely through a biopsy specimen obtained from the lip. A 64-year-old man had dysphagia, swelling of the oral mucosa and the posterior cervical muscles, accompanied by an abdominal pain and diarrhea. Peripheral blood cell count showed marked eosinophilia. Computed tomography showed thickening of posterior wall of the pharynx, esophagus, and gastrointestinal tract. Histologic specimen obtained from the lower lip demonstrated a moderate infiltration of eosinophils. His clinical condition was improved by oral prednisolone therapy.


Subject(s)
Esophagus/pathology , Hypereosinophilic Syndrome/diagnosis , Intestine, Small/pathology , Mouth Mucosa/pathology , Deglutition Disorders/etiology , Glucocorticoids/therapeutic use , Humans , Hypereosinophilic Syndrome/drug therapy , Hypereosinophilic Syndrome/pathology , Lip/pathology , Male , Middle Aged , Prednisolone/therapeutic use , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...